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ABSTRACT
Reactome (http://www.reactome.org) is a manually
curated open-source open-data resource of human
pathways and reactions. The current version 46 de-
scribes 7088 human proteins (34% of the predicted
human proteome), participating in 6744 reactions
based on data extracted from 15 107 research
publications with PubMed links. The Reactome
Web site and analysis tool set have been completely
redesigned to increase speed, flexibility and user
friendliness. The data model has been extended
to support annotation of disease processes due to
infectious agents and to mutation.
INTRODUCTION
At the cellular level, life is a network of molecular reac-
tions that can be organized into higher order intercon-
nected pathways. Molecules are synthesized, degraded,
transported from one location to another and assembled
into complexes and higher order structures with other
molecules. Intensive studies of cellular signaling,
motility, vesicular trafﬁcking and other aspects of cell
biology, coupled with the development of comprehensive
catalogs of human genes and their protein products, have
enabled the description of many cellular processes in the
same molecular detail that has been a standard for meta-
bolic processes for a generation. By annotating all of these
processes in a single, consistent reaction-pathway format,
the Reactome Knowledgebase systematically links human
proteins to their molecular functions, providing a resource
that functions both as an archive of biological processes
and as a tool for discovering unexpected functional rela-
tionships in data from gene expression pattern surveys or
somatic mutation catalogues from tumor cells (e.g. 1–3).
Since its inception 10 years ago, Reactome has grown to
include (version 46–September 2013) annotations for 7088
of the 20 774 protein-coding genes in the current Ensembl
human genome assembly (34% coverage), 15 107 literature
references and 1421 small molecules organized into 6744
reactions collected in 1481pathways. Notable recent add-
itions include extensive annotations of phospholipid and
eicosanoid metabolism, protein glycosylation and SCF-
KIT, IGF1R, NOTCH and HIPPO signaling, as well as
annotations of regulatory processes mediated by non-
coding RNAs.
Here, we will focus on three new features of Reactome:
the development of a strategy to annotate the disease
counterparts of normal human processes, the deployment
of a redesigned Web site and the extension of tools for
data analysis.
Disease curation using an enhanced data model
The Reactome data model (4) builds on earlier work by
Kanehisa et al. (5) and Karp et al. (6) to classify and
catalog physical entities (proteins and other macromol-
ecules, small molecules, complexes of these entities and
post-translationally modiﬁed forms of them), their
subcellular locations and the transformations they can
undergo (biochemical reaction, association to form a
complex and translocation from one cellular compartment
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to another). The central class of the Reactome data model
is a Reaction, and subclasses of Reaction model these core
biological events. Reactions are grouped into pathways,
which in turn are assembled into a hierarchy of biological
processes. Wherever appropriate, Reactome entities are
linked to external reference databases such as UniProt
(7), Ensembl (8), ChEBI (9) and Rhea (10). The full
Reactome database schema is available at http://www.
reactome.org/cgi-bin/classbrowser?DB=gk_current.
A straightforward deﬁnition of disease allows us to
annotate a broad range of major disease processes at the
molecular level. Diseases that can now be annotated in
Reactome arise in one of three ways: a mutation, somatic
or germ-line, leads to a non-functional gene product so
processes that normally depend on that gene product do
not take place; a mutation leads to a gene product with a
novel function, enabling novel reactions whose products
perturb normal human processes; or an infectious agent
such as a virus introduces novel gene products whose
novel reactions perturb normal human processes.
To identify disease-associated entities and events, a new
‘disease’ attribute is added, taking its value terms from a
disease ontology [currently http://disease-ontology.org/
(11)]. This attribute is multivalued, so an entity or event
that has roles in multiple disease processes can be
annotated to capture all of those roles.
With this addition, diseases due to infection can be
annotated within our data structure. Our existing
‘species’ attribute allows pathogen-derived proteins,
DNA and RNA to be distinguished from molecules
encoded in the human genome. The ‘species’ attribute,
also associated with complexes, reactions and pathways,
can be multivalued, allowing complexes containing both
host and viral proteins or reactions involving host and
viral components to be properly identiﬁed. Finally,
addition of Gene Ontology (GO) (12) host_cell terms to
our cell compartment vocabulary allows us to localize
pathogen-derived entities accurately, in compliance with
GO annotation practice.
To denote molecular properties of a protein modiﬁed
by a somatic or germline mutation in the gene that
encodes it, as opposed to post translational modiﬁca-
tion, we created a new class. This class of genetic modi-
ﬁcations has subclasses to accommodate substitution of
a canonical residue by a different one, the insertion or
deletion of multiple contiguous residues into a canonical
sequence and the generation of a fusion protein contain-
ing fragments of two canonical ones (13). The
underlying chemical similarity between a protein that
differs from its canonical form due to a mutation and
one that differs due to co- or post-translational modiﬁ-
cation allows us to maintain compliance with the
PSI-MOD standard for annotation of protein
modiﬁcations (14).
Reactions involving mutated proteins as catalysts,
inputs, outputs and regulators are annotated exactly as
wild-type reactions are. To link reactions involving a
mutated protein to those involving its normal counterpart,
an optional ‘normal reaction’ attribute is used. A reaction
in which a receptor constitutively activated by a mutation
transmits a signal is thereby paired with the wild-type
reaction in which a normal receptor is activated by
ligand binding. A reaction catalyzed by the normal form
of an enzyme is paired with the different one catalyzed by
its gain-of-function mutant counterpart or with a dead-
end reaction (normal inputs, no outputs) associated with
its loss-of-function mutant counterpart. A limitation of
this strategy at present is that, as Reactome does not
capture quantitative data such as reaction rates or
binding afﬁnities, quantitative effects of mutations are
not readily annotated.
At the level of our event hierarchy, these normal-disease
pairings support a disease event hierarchy that parallels
our normal event hierarchy, a useful and generalizable
organization. These pairings also support a visualization
scheme that highlights the relationship between the
normal and disease processes. As described previously
(15), the physical entities and their interactions that
Figure 1. Example of disease curation and visualization in Reactome. The normal process of glucose export from the liver under fasting conditions
(A) is disrupted by mutations that block glucose-6-phosphate hydrolysis within the endoplasmic reticulum (B) or the transport of glucose
6-phosphate and orthophosphate (Pi) between the endoplasmic reticulum and the cytosol (C).
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comprise a pathway are laid out in a pathway diagram
that follows the SBGN process description language
(http://www.sbgn.org/Documents/Speciﬁcations) and
that is displayed on our Web site. The software that gen-
erates these displays has been extended to create disease
displays in which the variant forms of the events respon-
sible for a disease process are superimposed and high-
lighted on the normal process diagram (Figure 1).
We have used these extensions of the Reactome data
model and pathway visualization process to create a new
disease pathway classiﬁcation in our event hierarchy that
incorporates existing material such as the HIV and inﬂu-
enza life cycles, amyloid formation and botulinus toxin
neurotoxicity, together with new material that includes
malignant transformation due to mutations in the
EGFR and FGFR signaling pathways and mucopolysac-
charidoses. Our current release includes annotations for
420 mutant forms of 68 proteins.
Updated Reactome Web site
Our home page has been redesigned completely to support
intuitive access to our pathway browsing and data analysis
tools. The new Web site retains a top menu bar to provide
easy access to all of our tools and resources, accompanied
by a central panel of links to our most widely used tools
and a footer that displays all tools and resources. This
organization is consistent with the general model for
resources associated with EBI. News is now available as
an interactive Twitter display, which also provides open
real-time feedback, both by the Reactome group and our
user community.
Dynamic pathway portal
We have improved the ﬂexibility and performance of our
pathway browser by creating a new pathway diagram
visualization tool using the canvas element introduced in
HTML 5. The canvas element is used to render whole
pathway diagrams in a Google map-like way with XML-
encoded pathway diagram data retrieved from the server
using a RESTful API (Figure 2A). The new diagram
visualization tool offers quicker performance and better
data overlaying technologies (see later in text) and
bypasses the slow step to generate static images during
database release.
The event hierarchy panel to the left has been re-
designed to provide interactivity and access to the entire
listing of all the Reactome pathways. Icons now indicate
whether a pathway is new (N) or updated (U), and identify
ones that are parts of disease processes (+). Navigation
controls in the upper left corner enable zooming and
panning across the pathway panel. A diagram thumbnail
in the lower left shows the part of the pathway currently
displayed in the visualization panel. A widget icon in the
upper right corner of the panel links to tools for searching
within the displayed pathway, overlaying the pathway
with functional interactors (see later in text) and for down-
loading the diagram as a snapshot or PNG ﬁle.
A new tabbed ‘Details’ panel, below the pathway
diagram, provides additional graphical and textual
information. The ‘Overview’ tab provides summary
Figure 2. Visualization of the execution phase of apoptosis.
(A) Choosing the entry for this event from the event hierarchy in the
left panel of the web page causes the pathway to be displayed in a large
panel to the right, laid out in SBGN process description format. Buttons
at the top of the panel open a diagram key and give access to a brief tour of
features of the web page. The panel at the bottom of the page contains text
descriptions of various features of the pathway and participating mol-
ecules, linked to external databases. (B) The user has selected the
reaction ‘Caspase 3-mediated cleavage of PKC delta’; the ‘Structures’
detail tab displays PDB 3D structural data and citations for proteins in
that reaction and the ‘Expression’ detail tab (C) displays condition-
speciﬁc gene expression data from the Gene Expression Atlas. (D) The
molecular interaction (MI) overlay displays proteins that interact with
user-speciﬁed proteins PRKCQ and PRKCD.
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information relating to the pathway, reaction or entity
selected. The ‘Molecule’ tab displays external annotation
and linking-out to other bioinformatic resources
describing the selected molecule. The ‘Structures’ tab
(Figure 2B) displays 3D structural data and citations for
proteins from PDB (16), for small molecules from ChEBI
and for the stoichiometry of metabolic reactions from
Rhea. The ‘Expression’ tab (Figure 2C) serves condition-
speciﬁc gene expression data from the Gene Expression
Atlas (17). The ‘Processes’ tab displays Reactome
pathways and reactions associated with the selected
pathway node or event. Finally, the ‘Download’ tab
allows users to download the description of the pathway
in a variety of formats compatible with third-party tools.
Based on usability testing and feedback from our user
community, we modiﬁed the context sensitive menus. In
this new version, the mouse cursor can be positioned on
the pathway background and right-clicked to display a
new set of pathway diagram options.
The molecular interaction overlay that provides the
display of proteins or small molecules that interact with
Reactome pathway proteins (Figure 2D) is revised to
include additional interaction databases through the
PSIQUIC registry (18) including BindingDB (19),
DrugBank (20) and GeneMANIA (21).
Uniﬁed pathway analysis portal
We have merged pathway identiﬁer mapping, over-
representation and expression analysis tools into a single
tabbed data analysis portal with integrated visualization
and summary features (Figure 3). The pathway data
analysis module accepts gene lists or expression data
with numerical values (e.g. expression, abundance, fold
expression change and quality scores). It will automatic-
ally distinguish between tab-delimited, comma-delimited
or Microsoft Excel ﬁles and can cope with ﬁles that have
been ZIP compressed.
The results of an analysis are displayed in three tabs
that provide three different views of the same data.
Pathway-oriented expression analysis provides a table of
top-level pathways plus information relevant to the type
of data submitted by the user. If presented with a list of
identiﬁers, an enrichment analysis will be shown; numer-
ical data will be summarized in a graphical way, using
color to indicate average expression values. The identiﬁer
mapping view lists each of the identiﬁers supplied by the
user with the corresponding UniProt identiﬁer and a list of
pathways in Reactome in which it functions. The overview
is a completely new feature. It provides a canvas-based
aggregated summary of the entire set of Reactome
pathways, using visual cues to inform the user about the
Figure 3. Pathway analysis. The data analysis workﬂow proceeds in three steps: data submission, a tabular display of results and visual display of
results as an overlay in a pathway browser window. The fourth pane shows a detail of the pathway browser window, to highlight the display of
expression levels.
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number of participating entities, relations between the
pathways, average expression levels and other details.
The pathway names in the pathway-oriented view are
clickable links, which take the user to the relevant
pathway diagram. In it, the sub-pathway nodes, com-
plexes and entities are colored according to expression
level. Entities that lack gene expression information are
colored white. Pathway and complex nodes are colored
in vertical segments with each segment representing a
protein in the pathway or a component of the complex.
The segments are stacked in order from lowest to highest
expression level. A new icon at the base of the diagram
allows the user to single step through the individual
experiments or time points.
Community relationships and data exchange
Reactome continues to collaborate with other data re-
sources, such as GO, NCBI, EBI and WikiPathways
(22). Reactome provides a series of link-outs to many
online bioinformatics resources from its protein pages;
we have added links to GeneCards annotations (23).
Reactome is open-source and open-data, and we have
continuously supported the major open-data standards
in the domain, including BioPAX levels 2 and 3 (24),
PSI MITAB (18), Prote´ge´ (http://protege.stanford.edu),
SBML-ML (25) and SBGN export format. Reactome
now provides an SBGN ﬁle format generated using
libSBGN for individual pathways. The Reactome SBML
export has been upgraded to Level 2, Version 4 and is
enriched with a wide variety of additional annotations,
including Systems Biology Ontology terms (26).
Reactome also supports the Protein Ontology in develop-
ing an ontology for protein modiﬁcations and protein
complexes (27). Our new RESTful API provides outside
users with direct access to pathway data in Reactome.
The Reactome data model has been adopted by the
Gramene group for manual annotation of plant
pathways, especially metabolic processes speciﬁc to
plants. The current release of Plant Reactome (http://
plants.reactome.org) includes 131 rice pathways.
Since 2011, Reactome has participated in the Google
Summer of Code program as part of the Genome
Informatics group, helping to create the software compo-
nents for the new pathway browser, RESTful API and the
pathway overview. The Reactome data and source code
continues to be publically accessible under the terms of a
Creative Commons Attribution 3.0 Unported License.
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